"Mesenchymal" Stem Cells

被引:323
作者
Bianco, Paolo [1 ]
机构
[1] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy
来源
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 | 2014年 / 30卷
关键词
bone marrow stromal cells; bone marrow niche; pericyte; transplantation; cell therapy; MARROW STROMAL CELLS; HUMAN-BONE-MARROW; VERSUS-HOST-DISEASE; HEMATOPOIETIC STEM; IN-VITRO; FIBROUS DYSPLASIA; OSTEOBLAST DIFFERENTIATION; ALKALINE-PHOSPHATASE; PROGENITOR CELLS; PRECURSOR CELLS;
D O I
10.1146/annurev-cellbio-100913-013132
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Two opposing descriptions of so-called mesenchymal stem cells (MSCs) exist at this time. One sees MSCs as the postnatal, self-renewing, and multipotent stem cells for the skeleton. This cell coincides with a specific type of bone marrow perivascular cell. In skeletal physiology, this skeletal stem cell is pivotal to the growth and lifelong turnover of bone and to its native regeneration capacity. In hematopoietic physiology, its role as a key player in maintaining hematopoietic stem cells in their niche and in regulating the hematopoietic microenvironment is emerging. In the alternative description, MSCs are ubiquitous in connective tissues and are defined by in vitro characteristics and by their use in therapy, which rests on their ability to modulate the function of host tissues rather than on stem cell properties. Here, I discuss how the two views developed, conceptually and experimentally, and attempt to clarify the confusion arising from their collision.
引用
收藏
页码:677 / 704
页数:28
相关论文
共 205 条
  • [1] Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
    Akiyama, Kentaro
    Chen, Chider
    Wang, DanDan
    Xu, Xingtian
    Qu, Cunye
    Yamaza, Takayoshi
    Cai, Tao
    Chen, WanJun
    Sun, Lingyun
    Shi, Songtao
    [J]. CELL STEM CELL, 2012, 10 (05) : 544 - 555
  • [2] Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation
    Arai, F
    Ohneda, O
    Miyamoto, T
    Zhang, XQ
    Suda, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) : 1549 - 1563
  • [3] Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
    Armulik, Annika
    Genove, Guillem
    Betsholtz, Christer
    [J]. DEVELOPMENTAL CELL, 2011, 21 (02) : 193 - 215
  • [4] Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature
    Au, Patrick
    Tam, Joshua
    Fukumura, Dai
    Jain, Rakesh K.
    [J]. BLOOD, 2008, 111 (09) : 4551 - 4558
  • [5] Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease
    Badillo, Andrea T.
    Peranteau, William H.
    Heaton, Todd E.
    Quinn, Courtney
    Flake, Alan W.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 224 - 234
  • [6] The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
    Barry, FP
    Boynton, RE
    Haynesworth, S
    Murphy, JM
    Zaia, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) : 134 - 139
  • [7] Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons
    Beggs, Kirstin J.
    Lyubimov, Alex
    Borneman, Jade N.
    Bartholomew, Amelia
    Moseley, Annemarie
    Dodds, Robert
    Archambault, Michael P.
    Smith, Alan K.
    McIntosh, Kevin R.
    [J]. CELL TRANSPLANTATION, 2006, 15 (8-9) : 711 - 721
  • [8] BENNETT JH, 1991, J CELL SCI, V99, P131
  • [9] BERESFORD JN, 1992, J CELL SCI, V102, P341
  • [10] Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
    Bernardo, Maria Ester
    Fibbe, Willem E.
    [J]. CELL STEM CELL, 2013, 13 (04) : 392 - 402